dual beneficial effects of (-)-epigallocatechin-3-gallate on levodopa methylation and hippocampal neurodegeneration in vitro and in vivo studies双重好处(-)-epigallocatechin-3-gallate左旋多巴甲基化和海马神经退化体外和体内研究.pdfVIP

  • 3
  • 0
  • 约7.95万字
  • 约 14页
  • 2017-09-12 发布于上海
  • 举报

dual beneficial effects of (-)-epigallocatechin-3-gallate on levodopa methylation and hippocampal neurodegeneration in vitro and in vivo studies双重好处(-)-epigallocatechin-3-gallate左旋多巴甲基化和海马神经退化体外和体内研究.pdf

dual beneficial effects of (-)-epigallocatechin-3-gallate on levodopa methylation and hippocampal neurodegeneration in vitro and in vivo studies双重好处(-)-epigallocatechin-3-gallate左旋多巴甲基化和海马神经退化体外和体内研究

Dual Beneficial Effects of (-)-Epigallocatechin-3-Gallate on Levodopa Methylation and Hippocampal Neurodegeneration: In Vitro and In Vivo Studies Ki Sung Kang, Yujing Wen, Noriko Yamabe, Masayuki Fukui, Stephanie C. Bishop, Bao Ting Zhu* Department of Pharmacology, Toxicology and Therapeutics, School of Medicine, University of Kansas Medical Center, Kansas City, Kansas, United States of America Abstract Background: A combination of levodopa (L-DOPA) and carbidopa is the most commonly-used treatment for symptom management in Parkinson’s disease. Studies have

您可能关注的文档

文档评论(0)

1亿VIP精品文档

相关文档